Environmental epidemiology and risk factors for autoimmune disease

被引:78
作者
Dooley, MA [1 ]
Hogan, SL [1 ]
机构
[1] Univ N Carolina, Div Rheumatol & Immunol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1097/00002281-200303000-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has long been recognized that environmental influences play an important role in the risk of developing chronic rheumatic disease. Defining specific pathogenic environmental mediators that may trigger the development or progression of autoimmune disease remains a focus of increasing investigative effort. Factors promoting disease may not be identical to factors that influence the severity or progression of the disorder. Human monozygotic twin studies, animal studies, and genetic models demonstrate that genetic influences strongly determine whether one will develop autoimmunity, however, genes affecting the metabolism of exogenous agents that may trigger disease expression have only recently drawn attention. In this article the authors review recent reports that advance our understanding of previously recognized environmental risk factors and challenge accepted beliefs that increased estrogenic exposures predate the incidence of autoimmune disorders, systemic lupus erythematosus in particular. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:99 / 103
页数:5
相关论文
共 60 条
[11]  
BRUN JG, 1995, BRIT J RHEUMATOL, V34, P542
[12]   Occupational exposures and autoimmune diseases [J].
Cooper, GS ;
Miller, FW ;
Germolec, DR .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2002, 2 (2-3) :303-313
[13]   Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States [J].
Cooper, GS ;
Parks, CG ;
Treadwell, EL ;
St Clair, EW ;
Gilkeson, GS ;
Cohen, PL ;
Roubey, RAS ;
Dooley, MA .
LUPUS, 2002, 11 (03) :161-167
[14]   Hormonal and reproductive risk factors for development of systemic lupus erythematosus - Results of a population-based, case-control study [J].
Cooper, GS ;
Dooley, MA ;
Treadwell, EL ;
St Clair, EW ;
Gilkeson, GS .
ARTHRITIS AND RHEUMATISM, 2002, 46 (07) :1830-1839
[15]  
Cooper GS, 2001, J RHEUMATOL, V28, P2653
[16]  
COOPER GS, 2002, IN PRESS J CLIN EPID
[17]  
DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311
[18]   Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans [J].
Dooley, MA ;
Hogan, S ;
Jennette, C ;
Falk, R .
KIDNEY INTERNATIONAL, 1997, 51 (04) :1188-1195
[19]   NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSIS [J].
ESTES, D ;
CHRISTIAN, CL .
MEDICINE, 1971, 50 (02) :85-+
[20]   A MULTI-CENTER STUDY OF OUTCOME IN SYSTEMIC LUPUS-ERYTHEMATOSUS .1. ENTRY VARIABLES AS PREDICTORS OF PROGNOSIS [J].
GINZLER, EM ;
DIAMOND, HS ;
WEINER, M ;
SCHLESINGER, M ;
FRIES, JF ;
WASNER, C ;
MEDSGER, TA ;
ZIEGLER, G ;
KLIPPEL, JH ;
HADLER, NM ;
ALBERT, DA ;
HESS, EV ;
SPENCERGREEN, G ;
GRAYZEL, A ;
WORTH, D ;
HAHN, BH ;
BARNETT, EV .
ARTHRITIS AND RHEUMATISM, 1982, 25 (06) :601-611